Trial Profile
Phase I Trial of a PSA Based Vaccine and an Anti-CTLA-4 Antibody in Adults With Metastatic Androgen Independent Prostrate Cancer
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 03 Nov 2021
Price :
$35
*
At a glance
- Drugs Rilimogene galvacirepvec (Primary) ; Rilimogene glafolivec (Primary) ; Ipilimumab; Sargramostim
- Indications Adenocarcinoma; Prostate cancer
- Focus Adverse reactions
- 10 Oct 2016 According to a Bavarian Nordic media release, results from this trial were presented at 2015 Genitourinary Cancers Symposium 2015.
- 24 Feb 2015 According to a Bavarian Nordic media release, data from this trial will be presented at the 2015 Genitourinary Cancers Symposium.
- 24 Feb 2015 Results published in a Bavarian Nordic media release.